Hwa Jin Cho

Dr. Hwa Jin Cho

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2012 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
JMJae Kyung Myung
Jae Kyung Myung
HCHwa Jin Cho
Hwa Jin Cho
CPChul-kee Park
Chul-kee Park
SKSeung-Ki Kim
Seung-Ki Kim
JPJi Hoon Phi
Ji Hoon Phi
SPSung-Hye Park
Sung-Hye Park
A recurrent mutation affecting codon 132 of the isocitrate dehydrogenase 1 (IDH1) gene has been found in ~5% of primary glioblastomas (GBMs), but in >70% of secondary GBMs or oligodendroglial and astrocytic tumors. We investigated IDH1 mutations in a series of 134 brain tumors to determine the prevalence and prognostic impact of IDH1 mutations. We also examined the correlations among histology, p53 and PTEN immunoexpression, MGMT methylation status, 1p 19q co-deletion and EGFR gene amplification. The 134 brain tumors included 41 low-grade oligodendrogliomas (LOs), 47 anaplastic oligodendrogliomas (AOs) and 46 primary GBMs. Data showed that 53.7% (72/134) of cases showed mutations affecting codon 132 of IDH1, including 73.2% of LOs, 82.9% of AOs and three primary GBMs (6.5%). All IDH1 mutations were Arg132His. In a survival analysis, patients with IDH1 mutations had better survival compared to those with wild-type IDH1 (p<0.05) in LOs and AOs, but not in primary GBMs (p=0.587). In addition, in patients with both IDH1 mutation and MGMT methylation, p53 overexpression was a significant poor prognostic factor both in LOs and AOs. However, IDH1 mutation was not correlated with common genetic profiles that affect patient prognosis, including MGMT methylation, 1p 19q co-deletion, PTEN loss and EGFR amplification in LOs, AOs and GBMs. From our results, IDH1 mutation was an independent positive prognostic factor in LOs and AOs, especially in the absence of p53 overexpression.

4 June 2012 in Neuropathology
Verified
Journal Article
Closed access
PDF file
JMJae Kyung Myung
Jae Kyung Myung
HCHwa Jin Cho
Hwa Jin Cho
CPChul-kee Park
Chul-kee Park
CCChun Kee Chung
Chun Kee Chung
SCSeung Hong Choi
Seung Hong Choi
Sung-Hye ParkSung-Hye Park
Sung-Hye Park

1 January 2013 in The Korean Journal of Pathology
Verified
Journal Article
Open access
PDF file
KLKyu Sang Lee
Kyu Sang Lee
GCGheeyoung Choe
Gheeyoung Choe
KNKyung Han Nam
Kyung Han Nam
ASAn Na Seo
An Na Seo
SYSumi Yun
Sumi Yun
SPSung Hye Park
Sung Hye Park
Lee KS, et al. Korean J Pathol. 2013 Dec;47(6):541-548. http://dx.doi.org/10.4132/KoreanJPathol.2013.47.6.541

28 May 2019 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
JBJung Mi Byun
Jung Mi Byun
HCHwa Jin Cho
Hwa Jin Cho
HPHa Young Park
Ha Young Park
YKYoung Nam Kim
Young Nam Kim
KLKyung Bok Lee
Kyung Bok Lee
DJDae Hoon Jeong
Dae Hoon Jeong

15 May 2021 in Clinical and Experimental Pediatrics
Verified
Journal Article
Open access
PDF file
SHSilver Heinsar
Silver Heinsar
SRSainath Raman
Sainath Raman
JSJacky Y. Suen
Jacky Y. Suen
HCHwa Jin Cho
Hwa Jin Cho
John Francis FraserJohn Francis Fraser
John Francis Fraser
Acute fulminant myocarditis (AFM) occurs as an inflammatory response to an initial myocardial insult. Its rapid and deadly progression calls for prompt diagnosis with aggressive treatment measures. The demonstration of its excellent recovery potential has led to increasing use of mechanical circulatory support, especially extracorporeal membrane oxygenation (ECMO). Arrhythmias, organ failure, elevated cardiac biomarkers, and decreased ventricular function at presentation predict requirement for ECMO. In these patients, ECMO should be considered earlier as the clinical course of AFM can be unpredictable and can lead to rapid haemodynamic collapse. Key uncertainties that clinicians face when managing children with AFM such as timing of initiation of ECMO and left ventricular decompression need further investigation.

30 June 2020 in Archives of Craniofacial Surgery
Verified
Journal Article
Open access
PDF file
IKIn Suk Koh
In Suk Koh
HCHwa Jin Cho
Hwa Jin Cho
JKJin Woo Kim
Jin Woo Kim
Pilomatricoma is a benign tumor arising from the primitive basal cells of the epidermis that differentiate into hair matrix cells. Mutations in the CTNNB1 gene, which encodes β-catenin (a protein involved in hair growth), play an etiological role in the development of pilomatricoma. A 34-yearold woman presenting with a mass in the right parotid region underwent an excisional biopsy. The mass was conclusively diagnosed as pilomatricoma. During pregnancy, the mass grew from 1 cm to 5 cm in diameter and was accompanied by pain and tenderness. The growth may have been facilitated by the increased production of estrogen and progesterone, which bind to receptors located in the outer root sheath cells of the hair follicles. No recurrence was observed during 6 months of follow-up.